Applications for licenses in Form 28‑D/28‑DA for r‑DNA products must now be submitted exclusively through the Online National Drugs Licensing System (ONDLS) portal. Offline submissions will no longer be accepted after March 10, 2026. Applicants should follow the checklist provided in the online module for compliance.
The regulatory authority, CDSCO has announced that applications for the grant of licenses in Form 28‑D and 28‑DA for r‑DNA products must now be submitted exclusively through the Online National Drugs Licensing System (ONDLS) portal at https://statedrugs.gov.in.
This initiative aims to streamline and modernize the submission process, ensuring efficiency and transparency in regulatory approvals. All applicants are required to follow the checklist provided in the online module when submitting their applications.
Importantly, the facility for offline submission of applications in hard copy will be discontinued and will not be accepted for processing after March 10, 2026.
Stakeholders are advised to transition to the online system promptly to avoid delays in licensing procedures.